What You Should Know About KBroVet®-CA1: The Once-Daily Option for Canine Epilepsy
Now, with the introduction of KBroVet®-CA1 by PRN Pharmacal, veterinarians have a new, promising solution. This is the first FDA-conditionally approved potassium bromide medication designed specifically for dogs with idiopathic epilepsy—and it brings with it a host of advantages for both clinicians and clients.
The Future of Veterinary Neurology Is Now—and It Has Swagger
This edition spotlights three groundbreaking veterinary neurologists who are doing more than practicing medicine—they’re reshaping the future of the profession with brilliance, boldness, and undeniable presence. Meet Dr. Philip Cohen (Connecticut), Dr. Gaemia Tracy (Pennsylvania), and Dr. Richard Joseph (New York), each bringing their own brand of leadership, innovation, and insight to the specialty.